FDA NEWS

AMAG Pharmaceuticals, Inc. to Webcast Upcoming Analyst and Investor - MSN MoneyCentral
AMAG Pharmaceuticals, Inc. AMAG today announced it will webcast its Analyst and Investor meeting taking place on June 6, 2008 in New York City beginning at 8:00 am ET. At the meeting, the Company intends to discuss the ferumoxytol development program
Source: news.moneycentral.msn.com

FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief - Phramalive.com
http://www.exlpharma.com ) is pleased to announce the participation of two keynote speakers from the U.S. Food and Drug Administration and Verizon during the 4th Annual Public Relations and Communications Summit: The Leading Event for Pharmaceutical
Source: www.pharmalive.com

FDA proposes change to physician labeling - United Press International
WASHINGTON, May 29 (UPI) -- The U.S. Food and Drug Administration said it is proposing major revisions to the physician labeling of prescription drugs. FDA officials said the proposed changes would provide better information about the effects of
Source: www.upi.com

Wyeth Receives Approvable Letter from FDA for TYGACIL for the - Phramalive.com
COLLEGEVILLE, Pa., May 29, 2008 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , announced today that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for the first-in-class antibiotic TYGACIL(R
Source: www.pharmalive.com

FDA asks Xiadafil VIP Tabs be recalled - The Money Times
Washington -- The U.S. Food and Drug Administration said it has asked SEI Pharmaceuticals of Miami to recall all of its Xiadafil VIP Tabs. The FDA said the recalled drug -- sold in 8 tablet bottles (Lot 6K029) or blister cards of 2 tablets (Lot 6K029
Source: www.themoneytimes.com

FDA Approvals: Entereg and Aranesp CME - Medscape News
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) ™ for physicians; Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians To participate in this internet activity: (1) review the target audience, learning objectives, and
Source: www.medscape.com